This suggests that aromatase expression in the vicinity of breast tumors is controlled by a rather labile signaling environment, where Wnt signaling above a critical threshold will result in a switch-off of estrogen responsiveness/aromatase expression. This evidence concerns the gene CYP19A1 and breast neoplasm.